Accenture Jumped 28% in a Month and Now Trades Above Two Analysts’ $252 Targets
Accenture's shares rose 28% in a month, surpassing $252 price targets from Baird and Wells Fargo. UBS raised its target to $300. Fiscal 2027 guidance projects 3-6% revenue growth, with 2-2.5% from acquisitions. Analysts expect $14.66 EPS, near the midpoint of guidance.
How this was made
The 30-second read
Why it matters
The earnings beat and guidance have been fully priced; the article mainly summarizes the reaction and target revisions.
Market read
Accenture's strong earnings have already driven a sizable price move; future trading interest will focus on valuation and guidance execution.
What to watch
Potential slowdown in AI services adoption and macro‑economic headwinds could temper future growth.
Background
Accenture reported fiscal Q4 revenue of $18.7 bn, beating its own range, and provided FY2027 guidance of 3‑6% revenue growth. Analysts raised price targets but the stock has already surged 28% in the past month.
Ticker impact
Article recaps Accenture's Q4 earnings and guidance that were released over a month ago, noting the 28% price rise and analyst target changes.
possible modest pullback as investors reassess valuation after the sharp rally
The earnings numbers and guidance are no longer new; the market has priced the beat, so any remaining move will be driven by valuation concerns rather than fresh fundamentals.
Market effects
Accenture's strong performance reinforces confidence in the broader consulting and technology services sector.
U.S. large‑cap tech stocks may see slight pressure as investors rotate from Accenture to other opportunities.
Limited; the news is specific to Accenture and does not affect global macro trends.
Counterpoint
The rally may be overstated; a correction could occur if growth guidance is not met.
Key entities
- CompanyAccenture
Global consulting and professional services firm (ticker ACN).
- AnalystBaird
Downgraded Accenture to Neutral while raising its price target.
- AnalystWells Fargo
Maintained Equal Weight rating and raised target to $252.
- AnalystUBS
Raised target to $300.
